Joleen M Hubbard, MD

  • 794 Citations
  • 16 Scopus h-Index
20082020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer

Jethwa, K. R., Jang, S., Mullikin, T. C., Harmsen, W. S., Petersen, M. M., Olivier, K. R., Park, S. S., Neben-Wittich, M. A., Hubbard, J. M., Sandhyavenu, H., Whitaker, T. J., Waltman, L. A., Kipp, B. R., Merrell, K. W., Haddock, M. G. & Hallemeier, C. L., May 2020, In : Radiotherapy and Oncology. 146, p. 29-36 8 p.

Research output: Contribution to journalArticle

Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)

Xie, H., Lafky, J. M., Morlan, B. W., Stella, P. J., Dakhil, S. R., Gross, G. G., Loui, W. S., Hubbard, J. M., Alberts, S. R. & Grothey, A., Jan 1 2020, In : Therapeutic Advances in Medical Oncology. 12

Research output: Contribution to journalArticle

Open Access

The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Sonbol, M. B., Mountjoy, L. J., Firwana, B., Liu, A. J., Almader-Douglas, D., Mody, K., Hubbard, J., Borad, M., Ahn, D. H., Murad, M. H. & Bekaii-Saab, T., Mar 2020, In : JAMA Oncology. 6, 3

Research output: Contribution to journalArticle

3 Scopus citations
2019

Intratumoral CD3+ and CD8+ T-cell densities in patients with DNA mismatch repair–deficient metastatic colorectal cancer receiving programmed cell death-1 blockade

Chakrabarti, S., Huebner, L. J., Finnes, H. D., Muranyi, A., Clements, J., Singh, S., Hubbard, J. M., McWilliams, R. R., Shanmugam, K. & Sinicrope, F. A., Jan 1 2019, In : JCO Precision Oncology. 3

Research output: Contribution to journalArticle

2 Scopus citations
2018

Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma

Kommalapati, A., Tella, S. H., Goyal, G., Borad, M. J., Alberts, S. R., Roberts, L. R., Hubbard, J. M., Durgin, L., Cleary, S. & Mahipal, A., Jan 1 2018, (Accepted/In press) In : HPB.

Research output: Contribution to journalArticle

1 Scopus citations

Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience

Jin, Z., Sanhueza, C. T., Johnson, B., Nagorney, D. M., Larson, D. W., Mara, K. C., Harmsen, W. C., Smyrk, T. C., Grothey, A. & Hubbard, J. M., Sep 2018, In : Oncologist. 23, 9, p. 1083-1091 9 p.

Research output: Contribution to journalArticle

7 Scopus citations
2017
54 Scopus citations

Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)

McCleary, N. J., Hubbard, J. M., Mahoney, M. R., Meyerhardt, J. A., Sargent, D., Venook, A. & Grothey, A. F., 2017, (Accepted/In press) In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

5 Scopus citations

Feasibility and acceptability of a dignity therapy/life plan intervention for patients with advanced cancer

Dose, A. M., Hubbard, J. M., Mansfield, A., McCabe, P. J., Krecke, C. A. & Sloan, J. A., Sep 1 2017, In : Oncology Nursing Forum. 44, 5, p. E194-E202

Research output: Contribution to journalArticle

4 Scopus citations

Non-V600BRAF mutations define a clinically distinct molecular subtype of metastatic colorectal cancer

Jones, J. C., Renfro, L. A., Al-Shamsi, H. O., Schrock, A. B., Rankin, A., Zhang, B. Y., Kasi, P. M., Voss, J. S., Leal, A. D., Sun, J., Ross, J., Ali, S. M., Hubbard, J. M., Kipp, B. R., Mc Williams, R. R., Kopetz, S., Wolff, R. A. & Grothey, A. F., Aug 10 2017, In : Journal of Clinical Oncology. 35, 23, p. 2624-2630 7 p.

Research output: Contribution to journalArticle

93 Scopus citations

Prescriber adherence to antiemetic guidelines with the new agent trifuridine-tipiracil

Childs, D. S., Jacobson, A. C., Mitchell, J. L., Hubbard, J. M., Yoon, H. H., Finnes, H., Grothey, A. F. & Jatoi, A., Jun 1 2017, In : Journal of Community and Supportive Oncology. 15, 3, p. e142-e146

Research output: Contribution to journalArticle

Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings

Houts, A. C., Ogale, S., Zafar, Y., Hubbard, J. M., Satram-Hoang, S., Sommer, N. & Walker, M. S., Oct 23 2017, (Accepted/In press) In : Journal of Gastrointestinal Cancer. p. 1-7 7 p.

Research output: Contribution to journalArticle

1 Scopus citations
2016

Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer

Zhang, B. Y., Jones, J. C., Briggler, A. M., Hubbard, J. M., Kipp, B. R., Sargent, D. J., Dixon, J. G. & Grothey, A. F., Jun 2 2016, (Accepted/In press) In : Clinical Colorectal Cancer.

Research output: Contribution to journalArticle

14 Scopus citations

Management of Colorectal Cancer in Older Adults

Hubbard, J. M., Feb 1 2016, In : Clinics in Geriatric Medicine. 32, 1, p. 97-111 15 p.

Research output: Contribution to journalArticle

9 Scopus citations
5 Scopus citations

Phase i trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies

Hubbard, J. M., Kim, G., Borad, M. J., Johnson, E., Qin, R., Lensing, J., Puttabasavaiah, S., Wright, J., Erlichman, C. & Grothey, A., Feb 1 2016, In : Investigational New Drugs. 34, 1, p. 96-103 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: Post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)

Ricotta, R., Verrioli, A., Ghezzi, S., Porcu, L., Grothey, A. F., Falcone, A., Van Cutsem, E., Argilés, G., Adenis, A., Ychou, M., Barone, C., Bouché, O., Peeters, M., Humblet, Y., Mineur, L., Sobrero, A. F., Hubbard, J. M., Cremolini, C., Prenen, H., Tabernero, J. & 15 others, Jarraya, H., Mazard, T., Deguelte-Lardiere, S., Papadimitriou, K., Van Den Eynde, M., Pastorino, A., Redaelli, D., Bencardino, K., Funaioli, C., Amatu, A., Carlo-Stella, G., Torri, V., Sartore-Bianchi, A., Vanzulli, A. & Siena, S., Dec 1 2016, In : ESMO Open. 1, 6, e000111.

Research output: Contribution to journalArticle

17 Scopus citations
2015
7 Scopus citations
11 Scopus citations

New Adjuvant Trial Designs in Colon Cancer

Leal, A. D., Hubbard, J. M., Sargent, D. & Grothey, A. F., Dec 1 2015, In : Current Colorectal Cancer Reports. 11, 6, p. 326-334 9 p.

Research output: Contribution to journalArticle

1 Scopus citations
35 Scopus citations

When less is more: Maintenance therapy in colorectal cancer

Hubbard, J. M. & Grothey, A. F., May 9 2015, In : The Lancet. 385, 9980, p. 1808-1810 3 p.

Research output: Contribution to journalArticle

10 Scopus citations
2014

Geriatric and non-geriatric cancer caregivers: Perceived benefits of technology

Lapid, M. I., Atherton, P. J., Clark, M. M., Kung, S., Richardson, J. W., Cheville, A. L., Dyrbye, L. L., Hubbard, J. M., Piderman, K. M., Shanafelt, T. D., Sloan, J. A., West, C. P., Schott, D. K. & Rummans, T. A., 2014, In : Gerontechnology. 13, 2, p. 231 1 p.

Research output: Contribution to journalArticle

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147

Gonsalves, W. I., Mahoney, M. R., Sargent, D. J., Nelson, G. D., Alberts, S. R., Sinicrope, F. A., Goldberg, R. M., Limburg, P. J., Thibodeau, S. N., Grothey, A., Hubbard, J. M., Chan, E., Nair, S., Berenberg, J. L. & McWilliams, R. R., Jul 9 2014, In : Journal of the National Cancer Institute. 106, 7, dju106.

Research output: Contribution to journalArticle

78 Scopus citations
15 Scopus citations
2013

Adolescent and young adult colorectal cancer

Hubbard, J. M. & Grothey, A., Oct 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 10, p. 1219-1225 7 p.

Research output: Contribution to journalArticle

38 Scopus citations
2012

Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: Findings from the adjuvant colon cancer endpoints data set

Hubbard, J., Thomas, D. M., Yothers, G., Green, E., Blanke, C., O'Connell, M. J., Labianca, R., Shi, Q., Bleyer, A., De Gramont, A. & Sargent, D., Jul 1 2012, In : Journal of Clinical Oncology. 30, 19, p. 2334-2339 6 p.

Research output: Contribution to journalArticle

18 Scopus citations
2011

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

Hubbard, J., Erlichman, C., Toft, D. O., Qin, R., Stensgard, B. A., Felten, S., Ten Eyck, C., Batzel, G., Ivy, S. P. & Haluska, P., Jun 1 2011, In : Investigational New Drugs. 29, 3, p. 473-480 8 p.

Research output: Contribution to journalArticle

29 Scopus citations
2010

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: Simulations based on the 20,800 patient ACCENT data set

De Gramont, A., Hubbard, J., Shi, Q., O'Connell, M. J., Buyse, M., Benedetti, J., Bot, B., O'Callaghan, C., Yothers, G., Goldberg, R. M., Blanke, C. D., Benson, A., Deng, Q., Alberts, S. R., Andre, T., Wolmark, N., Grothey, A. & Sargent, D., Jan 20 2010, In : Journal of Clinical Oncology. 28, 3, p. 460-465 6 p.

Research output: Contribution to journalArticle

54 Scopus citations
2009

Colorectal cancer and evidence for cure by adjuvant chemotherapy

Hubbard, J. & Sargent, D., Sep 1 2009, In : American Journal of Hematology/ Oncology. 8, 9

Research output: Contribution to journalArticle